A case of hyperprolactinemia in patient with metastatic breast cancer: clinical case presentation
https://doi.org/10.17650/1994-4098-2012-0-2-30-33
Abstract
The described clinical case illustrates the importance of careful medical care and follow-up for oncology patients which can prevent high degree of tumor dissemination in case of the disease progression and improve survival rate and quality of life.
About the Authors
L. K. Dzeranova
Department of Neuroendocrinology and Osteopathies, Endocrinology Research Center, Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
E. A. Pigarova
Department of Neuroendocrinology and Osteopathies, Endocrinology Research Center, Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
T. О. Vasilieva
Department of Neuroendocrinology and Osteopathies, Endocrinology Research Center, Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
O. V. Manchenko
Department of Neuroendocrinology and Osteopathies, Endocrinology Research Center, Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
V. P. Vladimirova
Department of Neuroendocrinology and Osteopathies, Endocrinology Research Center, Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
References
1. Soffietti R., Rudā R., Mutani R. Management of brain metastases. J Neurol 2002;249(10):1357−69.
2. Arslan U.Y., Oksuzoglu B., Aksoy S. et al. Breast cancer subtypes and outcomes of central nervous system metastases. Breast 2011.
3. Tse V. Brain metastasis. http://emedicine. medscape.com/article
4. EMRO Technical Publications Series. Guidelines for management of breast cancer/ by WHO Regional Office for the Eastern Mediterranean. World Health Organization, 2006.
5. Scottish Intercollegiate Guidelines Network. Management of breast cancer in women. A national clinical guideline, 2005.
6. New Zealand Guidelines Group. Manage- ment of Early Breast Cancer − Evidence- based Best Practice Guidelines. Wellington: New Zealand Guidelines Group, 2009.
7. Grunfeld E., Mant D., Yudkin P. et al. Routine follow up of breast cancer in primary care: randomised trial.
8. BMJ 1996;313:665−9.
9. Sturgeon C.M., Duffy M.J., Stenman U.H. et al. National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem 2008;54(12):11−79.
Review
For citations:
Dzeranova L.K., Pigarova E.A., Vasilieva T.О., Manchenko O.V., Vladimirova V.P. A case of hyperprolactinemia in patient with metastatic breast cancer: clinical case presentation. Tumors of female reproductive system. 2012;(2):30-33. (In Russ.) https://doi.org/10.17650/1994-4098-2012-0-2-30-33
Views:
739
Email this article 